Japanese pharmaceutical company Kyowa Kirin — which in February said it would build a $200 million plant in Sanford — is actually planning to spend more than twice that amount in the Lee ...

Sanford will be getting over 100 new jobs in ... with the U.S. branch of Japanese pharmaceutical research company Kyowa Kirin. In exchange for the 102 jobs and millions of dollars in promised ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Kura Oncology and Kyowa Kirin claim to have scored a phase 2 win for their oral leukemia treatment while reassuring analysts about the lack of any hard data to prove it. Ziftomenib, an oral ...

German pharma Grünenthal has started the process of taking ownership of 13 ageing medicines developed by Japan's Kyowa Kirin, which are currently sold by affiliate companies across Europe. The ...

Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the ...

Kyowa Kirin is letting go of 52 employees in Princeton, according to the state's WARN report. The Japanese pharma consolidated its New Jersey operations into a new North America headquarters in ...

Kyowa Kirin ploughed ahead with KW-6356 despite the reservations of its former partner Lundbeck, which held the rights to KW-6356 outside Asia before handing them back to the Japanese company.

The Japanese pharmaceutical company Kyowa Kirin Co. plans to sell shares in the Chinese division of the Hong Kong company WinHealth Pharma Group Co. for 15 billion yen ($100 million) as part of the ...

The enhanced partnership provides enterprise-wide access to AlphaMeld Corporation’s proprietary AI-powered AlphaMeld ® platform, further accelerating Kyowa Kirin’s innovative drug discovery ...